BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7811304)

  • 1. Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase.
    Panousis C; Kettle AJ; Phillips DR
    Biochem Pharmacol; 1994 Dec; 48(12):2223-30. PubMed ID: 7811304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase oxidizes mitoxantrone to metabolites which bind covalently to DNA and RNA.
    Panousis C; Kettle AJ; Phillips DR
    Anticancer Drug Des; 1995 Dec; 10(8):593-605. PubMed ID: 8595120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase.
    Brück TB; Brück DW
    Biochimie; 2011 Feb; 93(2):217-26. PubMed ID: 20887767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of superoxide and myeloperoxidase in ascorbate oxidation in stimulated neutrophils and H2O2-treated HL60 cells.
    Parker A; Cuddihy SL; Son TG; Vissers MC; Winterbourn CC
    Free Radic Biol Med; 2011 Oct; 51(7):1399-405. PubMed ID: 21791243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the peroxidase-derived metabolite of mitoxantrone with nucleic acids. Evidence for covalent binding of 14C-labeled drug.
    Reszka K; Hartley JA; Kolodziejczyk P; Lown JW
    Biochem Pharmacol; 1989 Dec; 38(23):4253-60. PubMed ID: 2597197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion and inactivation of myeloperoxidase by isolated neutrophils.
    King CC; Jefferson MM; Thomas EL
    J Leukoc Biol; 1997 Mar; 61(3):293-302. PubMed ID: 9060452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dimethylthiourea on the neutrophil myeloperoxidase pathway.
    Sagone AL; Husney RM; Wewers MD; Herzyk DJ; Davis WB
    J Appl Physiol (1985); 1989 Sep; 67(3):1056-62. PubMed ID: 2551876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of simultaneous stimulation of 5-lipoxygenase and myeloperoxidase in human neutrophils.
    Zschaler J; Arnhold J
    Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():12-21. PubMed ID: 27033421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the myeloperoxidase-H2O2-Cl- system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs.
    Shacter E; Lopez RL; Pati S
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):975-84. PubMed ID: 1848981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone.
    Kolodziejczyk P; Reszka K; Lown JW
    Free Radic Biol Med; 1988; 5(1):13-25. PubMed ID: 3254299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites.
    Khan SR; Morgan AG; Michail K; Srivastava N; Whittal RM; Aljuhani N; Siraki AG
    Biochem Pharmacol; 2016 Apr; 106():46-55. PubMed ID: 26867495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase-knockout mouse.
    Noguchi N; Nakano K; Aratani Y; Koyama H; Kodama T; Niki E
    J Biochem; 2000 Jun; 127(6):971-6. PubMed ID: 10833264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of the superoxide adduct of myeloperoxidase (compound III) by stimulated human neutrophils and its reactivity with hydrogen peroxide and chloride.
    Winterbourn CC; Garcia RC; Segal AW
    Biochem J; 1985 Jun; 228(3):583-92. PubMed ID: 2992450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA.
    Panousis C; Kettle AJ; Phillips DR
    Cancer Lett; 1997 Feb; 113(1-2):173-8. PubMed ID: 9065819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for oxidative activation of mitoxantrone in human, pig, and rat.
    Blanz J; Mewes K; Ehninger G; Proksch B; Waidelich D; Greger B; Zeller KP
    Drug Metab Dispos; 1991; 19(5):871-80. PubMed ID: 1686230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
    van Zyl JM; Basson K; Kriegler A; van der Walt BJ
    Biochem Pharmacol; 1991 Jul; 42(3):599-608. PubMed ID: 1650217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative inactivation of pneumolysin by the myeloperoxidase system and stimulated human neutrophils.
    Clark RA
    J Immunol; 1986 Jun; 136(12):4617-22. PubMed ID: 3011897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants.
    Sepe SM; Clark RA
    J Immunol; 1985 Mar; 134(3):1896-901. PubMed ID: 2981926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deuterium oxide on neutrophil oxidative metabolism, phagocytosis, and lysosomal enzyme release.
    Tsan MF; Turkall RM
    Inflammation; 1982 Dec; 6(4):387-96. PubMed ID: 6298110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
    Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.